Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Pharmacologic modulators of fracture healing: the role of cyclooxygenase inhibition.

Puzas JE, O'Keefe RJ, Schwarz EM, Zhang X.

J Musculoskelet Neuronal Interact. 2003 Dec;3(4):308-12; discussion 320-1. No abstract available.

2.

Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process.

Vuolteenaho K, Moilanen T, Moilanen E.

Basic Clin Pharmacol Toxicol. 2008 Jan;102(1):10-4. Epub 2007 Oct 31. Review.

3.

Role of the different isoforms of cyclooxygenase and nitric oxide synthase during gastric ulcer healing in cyclooxygenase-1 and -2 knockout mice.

Schmassmann A, Zoidl G, Peskar BM, Waser B, Schmassmann-Suhijar D, Gebbers JO, Reubi JC.

Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G747-56. Epub 2005 Dec 22.

4.

The role of cyclooxygenase-2 inhibition in foot and ankle arthrodesis.

Hill K, Berlet GC, Philbin TM, Lee TH.

Foot Ankle Clin. 2005 Dec;10(4):729-42, x. Review.

PMID:
16297830
5.

Role of cyclooxygenase isoforms in gastric mucosal defense and ulcer healing.

Peskar BM.

Inflammopharmacology. 2005;13(1-3):15-26. Review.

PMID:
16259725
6.

Cyclooxygenase-2 inhibitors in human skeletal fracture healing.

Daluiski A, Ramsey KE, Shi Y, Bostrom MP, Nestor BJ, Martin G, Hotchkiss R, Stephan DA.

Orthopedics. 2006 Mar;29(3):259-61.

PMID:
16539205
7.

Retroviral-based gene therapy with cyclooxygenase-2 promotes the union of bony callus tissues and accelerates fracture healing in the rat.

Rundle CH, Strong DD, Chen ST, Linkhart TA, Sheng MH, Wergedal JE, Lau KH, Baylink DJ.

J Gene Med. 2008 Mar;10(3):229-41.

PMID:
18088065
8.

Pharmacologic agents in fracture healing.

Koester MC, Spindler KP.

Clin Sports Med. 2006 Jan;25(1):63-73, viii. Review.

PMID:
16324974
9.

Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis.

Goldhahn J, Scheele WH, Mitlak BH, Abadie E, Aspenberg P, Augat P, Brandi ML, Burlet N, Chines A, Delmas PD, Dupin-Roger I, Ethgen D, Hanson B, Hartl F, Kanis JA, Kewalramani R, Laslop A, Marsh D, Ormarsdottir S, Rizzoli R, Santora A, Schmidmaier G, Wagener M, Reginster JY.

Bone. 2008 Aug;43(2):343-7. doi: 10.1016/j.bone.2008.04.017. Epub 2008 May 7. Review.

PMID:
18544475
10.

Negative effect of parecoxib on bone mineral during fracture healing in rats.

Dimmen S, Nordsletten L, Engebretsen L, Steen H, Madsen JE.

Acta Orthop. 2008 Jun;79(3):438-44. doi: 10.1080/17453670710015373.

PMID:
18626809
11.

A comparison between the effects of acetaminophen and celecoxib on bone fracture healing in rats.

Bergenstock M, Min W, Simon AM, Sabatino C, O'Connor JP.

J Orthop Trauma. 2005 Nov-Dec;19(10):717-23.

PMID:
16314720
12.

[The effect of cyclooxygenase inhibitors on the bone and cartilage].

Burdan F.

Pol Merkur Lekarski. 2005 Jun;18(108):709-11. Review. Polish.

PMID:
16124389
13.

Cyclooxygenase-2 inhibition delays the attainment of peak woven bone formation following four-point bending in the rat.

Gregory LS, Forwood MR.

Calcif Tissue Int. 2007 Mar;80(3):176-83. Epub 2007 Mar 3.

PMID:
17334881
14.

Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats.

Hatazawa R, Ohno R, Tanigami M, Tanaka A, Takeuchi K.

J Pharmacol Exp Ther. 2006 Aug;318(2):691-9. Epub 2006 May 12.

15.

Fracture induced mobilization and incorporation of bone marrow-derived endothelial progenitor cells for bone healing.

Matsumoto T, Mifune Y, Kawamoto A, Kuroda R, Shoji T, Iwasaki H, Suzuki T, Oyamada A, Horii M, Yokoyama A, Nishimura H, Lee SY, Miwa M, Doita M, Kurosaka M, Asahara T.

J Cell Physiol. 2008 Apr;215(1):234-42. doi: 10.1002/jcp.21309.

PMID:
18205179
16.

The effects of local insulin delivery on diabetic fracture healing.

Gandhi A, Beam HA, O'Connor JP, Parsons JR, Lin SS.

Bone. 2005 Oct;37(4):482-90.

PMID:
16027060
17.

Effects of cyclooxygenase inhibitors on bone and cartilage metabolism--a review.

Nwadinigwe CU, Anyaehie UE.

Niger J Med. 2007 Oct-Dec;16(4):290-4. Review.

PMID:
18080582
18.

Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K/BxN serum-transfer arthritis.

Chen M, Boilard E, Nigrovic PA, Clark P, Xu D, Fitzgerald GA, Audoly LP, Lee DM.

Arthritis Rheum. 2008 May;58(5):1354-65. doi: 10.1002/art.23453.

19.

The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in bone.

Gamradt SC, Feeley BT, Liu NQ, Roostaeian J, Lin YQ, Zhu LX, Sharma S, Dubinett SM, Lieberman JR.

Anticancer Res. 2005 Jan-Feb;25(1A):107-15.

20.

Do steroids, conventional non-steroidal anti-inflammatory drugs and selective Cox-2 inhibitors adversely affect fracture healing?

Boursinos LA, Karachalios T, Poultsides L, Malizos KN.

J Musculoskelet Neuronal Interact. 2009 Jan-Mar;9(1):44-52. Review.

Supplemental Content

Support Center